Glioblastoma multiforme is a malignant tumor with a uniformly fatal course. Palliation achieved by conventional radiation and surgical techniques can be measured in terms of months. The urgent need for new avenues of approach prompted a review of current laboratory and clinical investigation relating to glioblastomas.
Tissue Culture and Heterotransplantation Neuroglial tumors have been grown by a variety of tissue culture techniques during the past 30 years. Russell and Bland37 studied 20 gliomas in tissue culture and established the basis for their identification and classification in vitro. Lumsden21 recently published his extensive experience with the astrocytoma-glioblastoma group of tumors and reviewed previous contributions to this subject. He differentiated normal and neoplastic astrocytes in plasma clot preparations by their rate of migration and by the number and branching of their processes. These observations were made in short-term cultures, and not until 1959 did Manuelidis26 report long-term culture of
WILSON CB. Glioblastoma Multiforme: Present Status. Arch Neurol. 1964;11(5):562–568. doi:10.1001/archneur.1964.00460230112012
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: